New hope for lupus patients: sirolimus shows promise in phase 3 trial
NCT ID NCT04582136
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study tests whether adding sirolimus to standard lupus therapy helps control active disease better than a placebo. It involves 146 adults with lupus who still have symptoms despite usual care. The main goal is to see if more people achieve a meaningful reduction in disease activity after 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100053, China
-
Shenzhen People's Hospital
Shenzhen, Guangdong, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
The First Hospital of China Medical University
Shenyang, Liaoning, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Conditions
Explore the condition pages connected to this study.